We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
13/9/2017 09:18 | The ftse is generally down and healthcare is generally down even more I am sure we are due a decision from FDA on Shingrix today - this is a critical approval for what is likely a blockbuster vaccine that is a huge improvement on the current option | romeike | |
13/9/2017 09:12 | >>Cannot understand the drop>> Dollar weakness? $1.33 against $1.30 a few days ago. | zho | |
13/9/2017 09:10 | 13th sept JP Morgan Caz neutral tp 1570p cut from 1750p | philanderer | |
13/9/2017 09:02 | Cannot understand the drop - so much good news emerging ..... ;0) | tradermichael | |
13/9/2017 08:55 | Bear trap before a big player ups their stake. I'm adding more at 1460p support, bottom of this move should be 1435p | ny boy | |
12/9/2017 20:29 | Shingrix decision tomorrow? | romeike | |
11/9/2017 11:50 | The market is up 45 points, Astra Zeneca is up 2%, GSK release some positive data on Asthma and yet the GSKshare price is struggling to get over 1500p. This does not look like a very positive phase for this company, which we think should have a share price of 1700p. Why is confidence so low?? | jadeticl3 | |
10/9/2017 11:56 | GBP strenghting v USD. | essentialinvestor | |
10/9/2017 11:18 | Which way is this going I'm sat ere waiting to get in | stevenrevell | |
08/9/2017 14:42 | They are just changing their TP to make them look less stupid. Pretty much all analysts change their tps to be closer. Finger in the air stuff | dr biotech | |
08/9/2017 12:05 | Another 'Analyst' fantasy. What was so right about 1700p - that's some revision - changed by £1 .....? | tradermichael | |
08/9/2017 10:28 | Downgraded today by Morgan Stanley to 'underweight' tp 1600p cut from 1700p | philanderer | |
08/9/2017 09:42 | As a visitor I think Harlow was a more pleasant place place to work. More green space on site. Must also say it's one of the better companies I have visited, everyone is welcoming and social, which isn't always the case in labs. | dr biotech | |
08/9/2017 08:22 | GlaxoSmithKline was downgraded to "underweight" from "equalweight" at Morgan Stanley. | mj19 | |
07/9/2017 16:17 | DrB - David Jack was a great guy. I am surprised it took so long to shut Harlow. | alphorn | |
07/9/2017 13:05 | These markets just throw up buying/adding opportunities | ny boy | |
07/9/2017 09:24 | R&D site. They are merging with Harlow (or to be more accurate Harlow is closing). There is a lot of lab stuff to move and requalify. It's the David jack centre if that means anything to you | dr biotech | |
07/9/2017 09:23 | just for a change :-) GlaxoSmithKline starts work on toothpaste factory | philanderer | |
07/9/2017 08:58 | Woodford making a public apology yesterday on recent performance. As I mentioned to a poster who wondered if Woodford selling GSK was good call, it may depends on where he then invested that money. | essentialinvestor | |
06/9/2017 21:10 | Dev or Secondary site? | alphorn | |
06/9/2017 20:08 | I have been at GSKs ware site this week. Nice bunch. Not sure about the current strategy but the people I know are too far down the food chain to have any influence. Free coffee and guest wifi makes it a decent place to call. | dr biotech | |
06/9/2017 16:26 | Off...ish topic - Reading Moderna’s mRNA approach is fascinating stuff. | alphorn | |
06/9/2017 11:43 | Analysts have their own agenda ..... ;0) | tradermichael | |
06/9/2017 11:28 | I remember HSBA When Goldman recomendTion for 770 and share when down to 420 .LOL | action | |
06/9/2017 08:51 | 6th sept Credit Suisse neutral tp 1725p cut from 1750p | philanderer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions